ID   UB2L3_HUMAN             Reviewed;         154 AA.
AC   P68036; B2R4A7; B4DDG1; B4DSZ4; E7EWS7; P51966; P70653; Q9HAV1;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 L3;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme L3;
DE   AltName: Full=L-UBC;
DE   AltName: Full=UbcH7;
DE   AltName: Full=Ubiquitin carrier protein L3;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2-F1;
DE   AltName: Full=Ubiquitin-protein ligase L3;
GN   Name=UBE2L3; Synonyms=UBCE7, UBCH7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8563171; DOI=10.1007/BF00354295;
RA   Robinson P.A., Leek J.P., Thompson J., Carr I.M., Bailey A.,
RA   Moynihan T.P., Coletta P.L., Lench N.J., Markham A.F.;
RT   "A human ubiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's
RT   disease locus on chromosome 14q24.3.";
RL   Mamm. Genome 6:725-731(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8576257; DOI=10.1074/jbc.271.5.2795;
RA   Nuber U., Schwarz S., Kaiser P., Schneider R., Scheffner M.;
RT   "Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-
RT   F1) and characterization of their interaction with E6-AP and RSP5.";
RL   J. Biol. Chem. 271:2795-2800(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=9693040; DOI=10.1006/geno.1998.5257;
RA   Moynihan T.P., Cole C.G., Dunham I., O'Neil L., Markham A.F.,
RA   Robinson P.A.;
RT   "Fine-mapping, genomic organization, and transcript analysis of the
RT   human ubiquitin-conjugating enzyme gene UBE2L3.";
RL   Genomics 51:124-127(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RA   Poloumienko A.;
RT   "Is retroposition a common way of spreading ubiquitin-conjugating
RT   enzyme genes throughout mammalian genomes?";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Adrenal gland, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 53-67; 67-74 AND 101-122.
RX   PubMed=8144544;
RA   Blumenfeld N., Gonen H., Mayer A., Smith C.E., Siegel N.R.,
RA   Schwartz A.L., Ciechanover A.;
RT   "Purification and characterization of a novel species of ubiquitin-
RT   carrier protein, E2, that is involved in degradation of non-'N-end
RT   rule' protein substrates.";
RL   J. Biol. Chem. 269:9574-9581(1994).
RN   [11]
RP   PROMOTER ANALYSIS.
RX   PubMed=10760570; DOI=10.1016/S0167-4781(00)00024-5;
RA   Ardley H.C., Moynihan T.P., Markham A.F., Robinson P.A.;
RT   "Promoter analysis of the human ubiquitin-conjugating enzyme gene
RT   family UBE2L1-4, including UBE2L3 which encodes UbcH7.";
RL   Biochim. Biophys. Acta 1491:57-64(2000).
RN   [12]
RP   FUNCTION, INTERACTION WITH PRKN, AND MUTAGENESIS OF CYS-86.
RX   PubMed=10888878; DOI=10.1038/77060;
RA   Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S.,
RA   Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T.;
RT   "Familial Parkinson disease gene product, parkin, is a ubiquitin-
RT   protein ligase.";
RL   Nat. Genet. 25:302-305(2000).
RN   [13]
RP   INTERACTION WITH RNF19A.
RX   PubMed=11237715; DOI=10.1006/bbrc.2001.4414;
RA   Niwa J., Ishigaki S., Doyu M., Suzuki T., Tanaka K., Sobue G.;
RT   "A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin
RT   ligase activity.";
RL   Biochem. Biophys. Res. Commun. 281:706-713(2001).
RN   [14]
RP   INTERACTION WITH ARIH1, AND SUBCELLULAR LOCATION.
RX   PubMed=11278816; DOI=10.1074/jbc.M011028200;
RA   Ardley H.C., Tan N.G.S., Rose S.A., Markham A.F., Robinson P.A.;
RT   "Features of the parkin/ariadne-like ubiquitin ligase, HHARI, that
RT   regulate its interaction with the ubiquitin-conjugating enzyme,
RT   Ubch7.";
RL   J. Biol. Chem. 276:19640-19647(2001).
RN   [15]
RP   INTERACTION WITH CCNB1IP1.
RX   PubMed=12612082; DOI=10.1128/MCB.23.6.2109-2122.2003;
RA   Toby G.G., Gherraby W., Coleman T.R., Golemis E.A.;
RT   "A novel RING finger protein, human enhancer of invasion 10, alters
RT   mitotic progression through regulation of cyclin B levels.";
RL   Mol. Cell. Biol. 23:2109-2122(2003).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH NCOA1.
RX   PubMed=15367689; DOI=10.1128/MCB.24.19.8716-8726.2004;
RA   Verma S., Ismail A., Gao X., Fu G., Li X., O'Malley B.W., Nawaz Z.;
RT   "The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for
RT   steroid hormone receptors.";
RL   Mol. Cell. Biol. 24:8716-8726(2004).
RN   [17]
RP   INTERACTION WITH RNF144B.
RX   PubMed=16427630; DOI=10.1016/j.febslet.2005.09.105;
RA   Huang J., Xu L.-G., Liu T., Zhai Z., Shu H.-B.;
RT   "The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent
RT   apoptosis.";
RL   FEBS Lett. 580:940-947(2006).
RN   [18]
RP   FUNCTION, INTERACTION WITH NR3C1, AND SUBCELLULAR LOCATION.
RX   PubMed=17003263; DOI=10.1677/joe.1.06799;
RA   Garside H., Waters C., Berry A., Rice L., Ardley H.C., White A.,
RA   Robinson P.A., Ray D.;
RT   "UbcH7 interacts with the glucocorticoid receptor and mediates
RT   receptor autoregulation.";
RL   J. Endocrinol. 190:621-629(2006).
RN   [19]
RP   INTERACTION WITH RNF19B.
RX   PubMed=16709802; DOI=10.4049/jimmunol.176.11.6454;
RA   Fortier J.M., Kornbluth J.;
RT   "NK lytic-associated molecule, involved in NK cytotoxic function, is
RT   an E3 ligase.";
RL   J. Immunol. 176:6454-6463(2006).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH ARIH2.
RX   PubMed=19340006; DOI=10.1038/leu.2009.57;
RA   Marteijn J.A., van der Meer L.T., Smit J.J., Noordermeer S.M.,
RA   Wissink W., Jansen P., Swarts H.G., Hibbert R.G., de Witte T.,
RA   Sixma T.K., Jansen J.H., van der Reijden B.A.;
RT   "The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and
RT   Ubc13 interacting domains.";
RL   Leukemia 23:1480-1489(2009).
RN   [21]
RP   FUNCTION, UBIQUITINATION, AND MUTAGENESIS OF CYS-86.
RX   PubMed=18946090; DOI=10.1091/mbc.E08-01-0036;
RA   Whitcomb E.A., Dudek E.J., Liu Q., Taylor A.;
RT   "Novel control of S phase of the cell cycle by ubiquitin-conjugating
RT   enzyme H7.";
RL   Mol. Biol. Cell 20:1-9(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-131 AND LYS-138, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION, DOMAIN, INTERACTION WITH PRKN AND ARIH1, AND MUTAGENESIS OF
RP   PRO-88 AND HIS-119.
RX   PubMed=21532592; DOI=10.1038/nature09966;
RA   Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E.;
RT   "UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT
RT   hybrids.";
RL   Nature 474:105-108(2011).
RN   [26]
RP   INTERACTION WITH NDFIP1.
RX   PubMed=25632008; DOI=10.4049/jimmunol.1402742;
RA   Kathania M., Zeng M., Yadav V.N., Moghaddam S.J., Yang B.,
RA   Venuprasad K.;
RT   "Ndfip1 regulates itch ligase activity and airway inflammation via
RT   UbcH7.";
RL   J. Immunol. 194:2160-2167(2015).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH UBE3A.
RX   PubMed=10558980; DOI=10.1126/science.286.5443.1321;
RA   Huang L., Kinnucan E., Wang G., Beaudenon S., Howley P.M.,
RA   Huibregtse J.M., Pavletich N.P.;
RT   "Structure of an E6AP-UbcH7 complex: insights into ubiquitination by
RT   the E2-E3 enzyme cascade.";
RL   Science 286:1321-1326(1999).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH 47-434 OF CBL
RP   AND ZAP70.
RX   PubMed=10966114; DOI=10.1016/S0092-8674(00)00057-X;
RA   Zheng N., Wang P., Jeffrey P.D., Pavletich N.P.;
RT   "Structure of a c-Cbl-UbcH7 complex: RING domain function in
RT   ubiquitin-protein ligases.";
RL   Cell 102:533-539(2000).
CC   -!- FUNCTION: Ubiquitin-conjugating enzyme E2 that specifically acts
CC       with HECT-type and RBR family E3 ubiquitin-protein ligases. Does
CC       not function with most RING-containing E3 ubiquitin-protein
CC       ligases because it lacks intrinsic E3-independent reactivity with
CC       lysine: in contrast, it has activity with the RBR family E3
CC       enzymes, such as PRKN and ARIH1, that function like function like
CC       RING-HECT hybrids. Accepts ubiquitin from the E1 complex and
CC       catalyzes its covalent attachment to other proteins. In vitro
CC       catalyzes 'Lys-11'-linked polyubiquitination. Involved in the
CC       selective degradation of short-lived and abnormal proteins. Down-
CC       regulated during the S-phase it is involved in progression through
CC       the cell cycle. Regulates nuclear hormone receptors
CC       transcriptional activity. May play a role in myelopoiesis.
CC       {ECO:0000269|PubMed:10888878, ECO:0000269|PubMed:15367689,
CC       ECO:0000269|PubMed:17003263, ECO:0000269|PubMed:18946090,
CC       ECO:0000269|PubMed:19340006, ECO:0000269|PubMed:20061386,
CC       ECO:0000269|PubMed:21532592}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:20061386}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with PRKN; involved in ubiquitination and
CC       degradation of misfolded proteins. Interacts with UBE3A; used by
CC       the papilloma virus HPV-16 E6 protein to ubiquitinate p53/TP53.
CC       Interacts with CCNB1IP1, CBL, ZAP70, RNF19A, RNF19B and RNF144B.
CC       Interacts with ARIH1. Interacts with ARIH2 (via RING-type 1).
CC       Interacts with NCOA1; they functionally interact to regulate
CC       progesterone receptor transcriptional activity. May interact with
CC       NR3C1. Interacts with NDFIP1 (via N-terminus); the interaction
CC       mediates recruitment of UBE2L3 to ITCH and causes MAP3K7
CC       ubiquitination (PubMed:25632008). {ECO:0000269|PubMed:10558980,
CC       ECO:0000269|PubMed:10888878, ECO:0000269|PubMed:10966114,
CC       ECO:0000269|PubMed:11237715, ECO:0000269|PubMed:11278816,
CC       ECO:0000269|PubMed:12612082, ECO:0000269|PubMed:15367689,
CC       ECO:0000269|PubMed:16427630, ECO:0000269|PubMed:16709802,
CC       ECO:0000269|PubMed:17003263, ECO:0000269|PubMed:19340006,
CC       ECO:0000269|PubMed:21532592, ECO:0000269|PubMed:25632008}.
CC   -!- INTERACTION:
CC       Q9Y4X5:ARIH1; NbExp=5; IntAct=EBI-711173, EBI-2514233;
CC       O95376:ARIH2; NbExp=12; IntAct=EBI-711173, EBI-711158;
CC       O15344:MID1; NbExp=3; IntAct=EBI-711173, EBI-2340316;
CC       Q99PZ6:ospG (xeno); NbExp=3; IntAct=EBI-711173, EBI-9316527;
CC       Q9BYM8:RBCK1; NbExp=3; IntAct=EBI-711173, EBI-2340624;
CC       Q6ZMZ0:RNF19B; NbExp=2; IntAct=EBI-711173, EBI-2466594;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11278816,
CC       ECO:0000269|PubMed:17003263}. Cytoplasm
CC       {ECO:0000269|PubMed:11278816, ECO:0000269|PubMed:17003263}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P68036-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P68036-2; Sequence=VSP_045152;
CC       Name=3;
CC         IsoId=P68036-3; Sequence=VSP_047342;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous, with highest expression in testis.
CC   -!- DOMAIN: In contrast to other ubiquitin-conjugating enzymes E2,
CC       residues essential for lysine reactivity are absent: Pro and a His
CC       residues are present instead of an Asp and an Asp residues in
CC       positions 88 and 119, respectively. {ECO:0000269|PubMed:21532592}.
CC   -!- PTM: Ubiquitinated. The alteration of UBE2L3 protein levels during
CC       the S-phase of the cell cycle is due to ubiquitin-dependent
CC       proteasomal degradation. {ECO:0000269|PubMed:18946090}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- CAUTION: PubMed:10760570 reported that UBE2L1, UBE2L2 and UBE2L4
CC       are most likely pseudogenes and the only expressed member of this
CC       subfamily seems to be UBE2L3. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S81003; AAB36017.1; -; mRNA.
DR   EMBL; X92962; CAA63538.1; -; mRNA.
DR   EMBL; AJ000519; CAA04156.1; -; mRNA.
DR   EMBL; AF300336; AAG17922.1; -; Genomic_DNA.
DR   EMBL; CR456606; CAG30492.1; -; mRNA.
DR   EMBL; AK293179; BAG56722.1; -; mRNA.
DR   EMBL; AK299985; BAG61806.1; -; mRNA.
DR   EMBL; AK311761; BAG34704.1; -; mRNA.
DR   EMBL; AP000553; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000558; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW59459.1; -; Genomic_DNA.
DR   EMBL; BC053368; AAH53368.1; -; mRNA.
DR   CCDS; CCDS13790.1; -. [P68036-1]
DR   CCDS; CCDS58795.1; -. [P68036-3]
DR   CCDS; CCDS58796.1; -. [P68036-2]
DR   RefSeq; NP_001243284.1; NM_001256355.1. [P68036-3]
DR   RefSeq; NP_001243285.1; NM_001256356.1. [P68036-2]
DR   RefSeq; NP_003338.1; NM_003347.3. [P68036-1]
DR   UniGene; Hs.108104; -.
DR   PDB; 1C4Z; X-ray; 2.60 A; D=1-154.
DR   PDB; 1FBV; X-ray; 2.90 A; C=1-154.
DR   PDB; 3SQV; X-ray; 3.30 A; C/D=1-154.
DR   PDB; 3SY2; X-ray; 3.27 A; C/D=1-154.
DR   PDB; 4Q5E; X-ray; 1.87 A; C=1-154.
DR   PDB; 4Q5H; X-ray; 2.00 A; C=1-154.
DR   PDB; 5HPT; X-ray; 2.84 A; C/F=2-154.
DR   PDBsum; 1C4Z; -.
DR   PDBsum; 1FBV; -.
DR   PDBsum; 3SQV; -.
DR   PDBsum; 3SY2; -.
DR   PDBsum; 4Q5E; -.
DR   PDBsum; 4Q5H; -.
DR   PDBsum; 5HPT; -.
DR   ProteinModelPortal; P68036; -.
DR   SMR; P68036; -.
DR   BioGrid; 113180; 136.
DR   DIP; DIP-6124N; -.
DR   IntAct; P68036; 29.
DR   MINT; MINT-5002693; -.
DR   STRING; 9606.ENSP00000344259; -.
DR   iPTMnet; P68036; -.
DR   PhosphoSitePlus; P68036; -.
DR   SwissPalm; P68036; -.
DR   BioMuta; UBE2L3; -.
DR   DMDM; 54039805; -.
DR   OGP; P51966; -.
DR   UCD-2DPAGE; P68036; -.
DR   EPD; P68036; -.
DR   MaxQB; P68036; -.
DR   PaxDb; P68036; -.
DR   PeptideAtlas; P68036; -.
DR   PRIDE; P68036; -.
DR   TopDownProteomics; P68036-1; -. [P68036-1]
DR   TopDownProteomics; P68036-2; -. [P68036-2]
DR   DNASU; 7332; -.
DR   Ensembl; ENST00000342192; ENSP00000344259; ENSG00000185651. [P68036-1]
DR   Ensembl; ENST00000458578; ENSP00000400906; ENSG00000185651. [P68036-3]
DR   Ensembl; ENST00000545681; ENSP00000445931; ENSG00000185651. [P68036-2]
DR   GeneID; 7332; -.
DR   KEGG; hsa:7332; -.
DR   UCSC; uc002zva.2; human. [P68036-1]
DR   CTD; 7332; -.
DR   DisGeNET; 7332; -.
DR   GeneCards; UBE2L3; -.
DR   HGNC; HGNC:12488; UBE2L3.
DR   HPA; HPA045609; -.
DR   HPA; HPA062415; -.
DR   MIM; 603721; gene.
DR   neXtProt; NX_P68036; -.
DR   OpenTargets; ENSG00000185651; -.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA37137; -.
DR   eggNOG; KOG0422; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00760000119012; -.
DR   HOGENOM; HOG000233455; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P68036; -.
DR   KO; K04552; -.
DR   OMA; ADGQIAC; -.
DR   OrthoDB; EOG091G0QDO; -.
DR   PhylomeDB; P68036; -.
DR   TreeFam; TF313043; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P68036; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2L3; human.
DR   EvolutionaryTrace; P68036; -.
DR   GeneWiki; UBE2L3; -.
DR   GenomeRNAi; 7332; -.
DR   PRO; PR:P68036; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000185651; -.
DR   CleanEx; HS_UBE2L3; -.
DR   ExpressionAtlas; P68036; baseline and differential.
DR   Genevisible; P68036; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; TAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0097027; F:ubiquitin-protein transferase activator activity; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0044770; P:cell cycle phase transition; IMP:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:UniProtKB.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IDA:UniProtKB.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IMP:UniProtKB.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Nucleotide-binding; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1    154       Ubiquitin-conjugating enzyme E2 L3.
FT                                /FTId=PRO_0000082476.
FT   ACT_SITE     86     86       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388,
FT                                ECO:0000255|PROSITE-ProRule:PRU10133}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     131    131       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     138    138       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1      9       MAASRRLMK -> MQVAAGTRGDTRLQEVALLPQLFDLLVL
FT                                GQRRARLLRQVPSALAGKDLAQLQAGATLAGYRRAHGPE
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047342.
FT   VAR_SEQ      10     41       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045152.
FT   MUTAGEN      86     86       C->S: Loss of catalytic activity.
FT                                Prevents ubiquitin-dependent proteasomal
FT                                degradation of UBE2L3.
FT                                {ECO:0000269|PubMed:10888878,
FT                                ECO:0000269|PubMed:18946090}.
FT   MUTAGEN      88     88       P->D: Does not convert into a lysine
FT                                reactive E2; when associated with D-119.
FT                                {ECO:0000269|PubMed:21532592}.
FT   MUTAGEN     119    119       H->D: Does not convert into a lysine
FT                                reactive E2; when associated with D-88.
FT                                {ECO:0000269|PubMed:21532592}.
FT   CONFLICT     15     15       R -> S (in Ref. 6; BAG61806).
FT                                {ECO:0000305}.
FT   CONFLICT     23     23       R -> C (in Ref. 4; AAG17922).
FT                                {ECO:0000305}.
FT   CONFLICT    118    118       E -> K (in Ref. 4; AAG17922).
FT                                {ECO:0000305}.
FT   HELIX         1     17       {ECO:0000244|PDB:4Q5E}.
FT   STRAND       20     27       {ECO:0000244|PDB:4Q5E}.
FT   TURN         29     31       {ECO:0000244|PDB:1FBV}.
FT   STRAND       34     39       {ECO:0000244|PDB:4Q5E}.
FT   TURN         44     48       {ECO:0000244|PDB:4Q5E}.
FT   STRAND       49     56       {ECO:0000244|PDB:4Q5E}.
FT   TURN         59     62       {ECO:0000244|PDB:4Q5E}.
FT   STRAND       67     72       {ECO:0000244|PDB:4Q5E}.
FT   STRAND       77     79       {ECO:0000244|PDB:1FBV}.
FT   STRAND       83     85       {ECO:0000244|PDB:4Q5E}.
FT   HELIX        88     90       {ECO:0000244|PDB:4Q5E}.
FT   TURN         92     94       {ECO:0000244|PDB:4Q5E}.
FT   HELIX       101    113       {ECO:0000244|PDB:4Q5E}.
FT   STRAND      117    119       {ECO:0000244|PDB:3SQV}.
FT   HELIX       123    131       {ECO:0000244|PDB:4Q5E}.
FT   HELIX       133    147       {ECO:0000244|PDB:4Q5E}.
SQ   SEQUENCE   154 AA;  17862 MW;  F5A30243BE3C9985 CRC64;
     MAASRRLMKE LEEIRKCGMK NFRNIQVDEA NLLTWQGLIV PDNPPYDKGA FRIEINFPAE
     YPFKPPKITF KTKIYHPNID EKGQVCLPVI SAENWKPATK TDQVIQSLIA LVNDPQPEHP
     LRADLAEEYS KDRKKFCKNA EEFTKKYGEK RPVD
//
